Chapter I development of peptide medicine industry
Section 1 Definition and classification of polypeptide drugs
1、 Definition of peptide medicine industry
2、 Types of peptide medicine industry
3、 Characteristics of peptide medicine industry
Section II analysis of peptide drug industry chain
1、 Economic characteristics of peptide medicine industry
2、 Peptide medicine industry
3、 Analysis of the industrial chain structure of polypeptide drugs
Section III status analysis of peptide medicine industry
1、 The influence of peptide medicine industry on economic growth
2、 The influence of peptide medicine industry on people's life
3、 Correlation degree of peptide medicine industry
Chapter II overall development of China's peptide drug industry in 2013-2017
Section I analysis on the scale of peptide medicine industry in China
1、 Analysis of the scale of peptide drug industry
2、 An analysis of the scale of personnel in peptide medicine industry
3、 Analysis on the asset scale of peptide medicine industry
4、 Analysis of market scale of peptide medicine industry
Section II Analysis on the production and marketing of Chinese peptide medicine industry
1、 Production analysis of peptide medicine industry
2、 Analysis on the sales of peptide medicine industry
3、 Analysis of production and marketing of peptide medicine industry
Section 3 Analysis of financial capacity of Chinese peptide medicine industry
1、 Analysis and prediction of the profitability of peptide medicine industry
2、 Analysis and prediction of debt paying ability of peptide pharmaceutical industry
3、 Analysis and prediction of the operational capacity of peptide medicine industry
4、 Analysis and prediction of development ability of peptide medicine industry
Chapter III policy and technical environment analysis of Chinese peptide medicine industry
Section I analysis on the policy and regulatory environment of peptide medicine industry
1、 Interpretation of the 13th five year plan of the industry
2、 Industry related standards overview
3、 Analysis of industry tax policy
4、 Analysis of industry environmental protection policies
5、 Industry policy trend and its influence
Section II technical environment analysis of peptide medicine industry
1、 International technology development trend
2、 Current situation of domestic technology level
3、 Main direction of scientific and technological innovation
Chapter IV market development analysis of Chinese peptide medicine industry in 2013-2017
Section I market operation analysis of Chinese peptide medicine industry
1、 Analysis on the demand of peptide drug industry in China market in 2013-2017
2、 Analysis on the production situation of peptide drug industry in China market in 2013-2017
3、 Analysis of technological development of polypeptide drug industry in China market in 2013-2017
4、 Product structure analysis of peptide drug industry in China market in 2013-2017
Section II Analysis on the price trend of Chinese peptide drug industry
1、 Analysis of the factors influencing the price of polypeptide drug property market in China
2、 Analysis of market price trend of Chinese peptide drug industry in 2013-2017
Section 3 main strategies for market development of Chinese peptide medicine industry
1、 Suggestions and Countermeasures for the development of peptide medicine industry in China
2、 Suggestions for the development of peptide medicine industry in China
Chapter V analysis of import and export market of Chinese peptide drug industry in 2013-2017
Section I market analysis of peptide drugs import and export
1、 Composition characteristics of import and export products
2、 Analysis of import and export market development in 2013-2017
Section II import and export data statistics of peptide medicine industry
1、 Statistics of polypeptide drug imports in 2013-2017
2、 Statistics of peptide drug exports in 2013-2017
Section III Analysis of regional pattern of peptide drug import and export
1、 Pattern of import regions
2、 Pattern of export regions
Section IV prediction of peptide drug import and export in 2018-2023
1、 Forecast of peptide drug import in 2018-2023
2、 Forecast of peptide drug export in 2018-2023
Chapter VI research and analysis of supply and demand of Chinese peptide drug industry in 2013-2017
Section I market demand analysis of Chinese peptide drug industry in 2013-2017
1、 Analysis of market demand scale of Chinese peptide drug industry in 2013-2017
2、 Analysis of factors influencing the market demand of Chinese peptide drug industry in 2013-2017
3、 Analysis of market demand pattern of Chinese peptide drug industry in 2013-2017
Section II market supply analysis of Chinese peptide drug industry in 2013-2017
1、 Analysis of market supply scale of Chinese peptide drug industry in 2013-2017
2、 Analysis of factors influencing market supply of Chinese peptide drug industry in 2013-2017
3、 Analysis of market supply pattern of Chinese peptide medicine industry in 2013-2017
Section III Analysis of supply and demand balance of Chinese peptide drug industry in 2013-2017
Chapter VII comprehensive analysis of market operation of peptide medicine industry in 2013-2017
Section I analysis of upstream operation of peptide drug industry in 2013-2017
1、 Introduction to the upstream of peptide medicine industry
2、 Analysis on the upstream development of peptide medicine industry
3、 Analysis of the influence of the upstream of peptide medicine industry on the peptide medicine industry
Section II downstream operation analysis of polypeptide drug industry in 2013-2017
1、 Introduction to the downstream of peptide medicine industry
2、 Analysis of the downstream development of peptide medicine industry
3、 Analysis of the downstream influence of peptide medicine industry on the industry
Chapter VIII analysis of competition pattern of Chinese peptide drug industry in 2013-2017
Section I competitive structure analysis of peptide medicine industry
1、 Competition among existing enterprises
2、 Analysis of potential entrants
3、 Threat analysis of alternatives
4、 Bargaining power of suppliers
5、 Customer bargaining power
Section II comparison of international competitiveness of polypeptide drug enterprises
1、 Factors of production
2、 Demand conditions
3、 Support and related industries
4、 Enterprise strategy, structure and competitive state
5、 The role of government
Section 3 Analysis of competitive pattern of peptide medicine industry
1、 Concentration analysis of peptide medicine industry
2、 Analysis on the competition degree of peptide medicine industry
Section IV competitive strategy analysis of polypeptide drug industry in 2013-2017
1、 Prospect of competition pattern of peptide drug industry in 2013-2017
2、 Competitive strategy analysis of peptide drug industry in 2013-2017
Chapter IX operation analysis of key regions of Chinese peptide drug industry in 2013-2017
Section I operation of peptide drug industry in East China from 2013 to 2017
Section II operation of peptide drug industry in South China from 2013 to 2017
Section III operation of peptide drug industry in Central China from 2013 to 2017
Section IV operation of polypeptide drug industry in North China from 2013 to 2017
Section V operation of polypeptide drug industry in Northwest China from 2013 to 2017
Section VI operation of peptide drug industry in Southwest China from 2013 to 2017
Section 7 concentration and competitiveness analysis of major provinces and cities
Chapter 10 competitiveness analysis of famous brand enterprises in Chinese peptide medicine industry in 2013-2017 (enterprises can choose)
Section I a. company
1、 Company profile
2、 Enterprise income and profit indicators
3、 Analysis of enterprise assets
4、 Composition of enterprise cost
5、 Analysis of enterprise competitiveness
Section II B. company
1、 Company profile
2、 Enterprise income and profit indicators
3、 Analysis of enterprise assets
4、 Composition of enterprise cost
5、 Analysis of enterprise competitiveness
Section III C. company
1、 Company profile
2、 Enterprise income and profit indicators
3、 Analysis of enterprise assets
4、 Composition of enterprise cost
5、 Analysis of enterprise competitiveness
Section IV D. company
1、 Company profile
2、 Enterprise income and profit indicators
3、 Analysis of enterprise assets
4、 Composition of enterprise cost
5、 Analysis of enterprise competitiveness
Section V E. company
1、 Company profile
2、 Enterprise income and profit indicators
3、 Analysis of enterprise assets
4、 Composition of enterprise cost
5、 Analysis of enterprise competitiveness
Chapter XI prediction and analysis of development prospect of Chinese peptide drug industry in 2018-2023
Section I analysis on the development prospect of the industry
1、 Analysis of the development prospect of the industry market
2、 Analysis of business opportunities in the industry market
3、 Interpretation of the industry's 13th five year plan
Section II market development trend forecast of Chinese peptide medicine industry in 2018-2023
1、 Industry demand forecast 2018-2023
2、 Industry supply forecast 2018-2023
3、 Forecast of market price trend of Chinese peptide drug industry in 2018-2023
Section III development trend forecast of peptide drug technology in China in 2018-2023
1、 New trend of product development
2、 New development of product technology
3、 Product technology development trend forecast
Section 4 SWOT model analysis of peptide medicine industry in China
1、 Advantage analysis
2、 Disadvantage analysis
3、 Opportunity analysis
4、 Risk analysis
Chapter 12 investment analysis of Chinese peptide drug industry in 2018-2023
Section I investment opportunity analysis of peptide medicine industry
1、 Investment area
2、 Major projects
Section II investment risk analysis of peptide medicine industry
1、 Market risk
2、 Cost risk
3、 Trade risk
Section 3 investment suggestions for peptide medicine industry
1、 Grasp the opportunity of national investment
2、 The implementation of Competitive Strategic Alliance
3、 Implementation of key customer strategy in the market
Shengnuo bio PRODUCT
Best sales manager contact
| Contacts | Roleagh |
|---|---|
| Tel | 86-28-88203630 |
| Fax | 86-28-88203630 |
| roleagh@gmail.com | |
| 2539328606 | |
| LEI LI |
About Shengnuo
Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.